Android app on Google Play

ThinkEquity Starts Navidea Biopharmaceuticals (NAVB) at Buy

June 29, 2012 7:18 AM EDT Send to a Friend
Get Alerts NAVB Hot Sheet
Price: $1.73 -1.14%

Rating Summary:
    3 Buy, 2 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 10 | New: 20
Trade NAVB Now!
Join SI Premium – FREE
ThinkEquity initiates coverage on Navidea Biopharmaceuticals (NYSE: NAVB) with a Buy. PT $6.00.

For an analyst ratings summary and ratings history on Navidea Biopharmaceuticals click here. For more ratings news on Navidea Biopharmaceuticals click here.

Shares of Navidea Biopharmaceuticals closed at $3.62 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

ThinkEquity

Add Your Comment